Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Inovio Pharmaceuticals, Inc. (INO)GlobeNewsWire • 02/10/26
Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Inovio Pharmaceuticals, Inc. Class Action LawsuitBusiness Wire • 02/09/26
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Inovio Pharmaceuticals, Inc. (INO) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the FirmGlobeNewsWire • 02/09/26
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INOGlobeNewsWire • 02/03/26
*CORRECTION*INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Inovio Pharmaceuticals, Inc. - INOGlobeNewsWire • 01/27/26
INO Investor Notice: Levi & Korsinsky Investigates Inovio Pharmaceuticals, Inc. for Securities Law ViolationsNewsfile Corp • 01/21/26
*CORRECTION*INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INOGlobeNewsWire • 01/20/26
*CORRECTION*INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INOGlobeNewsWire • 01/13/26
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INOPRNewsWire • 01/08/26
FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)PRNewsWire • 12/29/25
Inovio Pharmaceuticals, Inc. (INO) Presents at Piper Sandler 37th Annual Healthcare Conference TranscriptSeeking Alpha • 12/02/25
INOVIO Reports Third Quarter 2025 Financial Results and Recent Business HighlightsPRNewsWire • 11/10/25
INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in AdultsPRNewsWire • 11/03/25
INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat ConferencePRNewsWire • 10/23/25
Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature MedicinePRNewsWire • 10/21/25
Inovio Pharmaceuticals, Inc. (INO) Presents At H.C. Wainwright 27th Annual Global Investment Conference (Transcript)Seeking Alpha • 09/05/25
INO Stock Soars as FDA Backs Rolling BLA for Rare Lung Disease DrugZacks Investment Research • 08/28/25